Imunovir

Inosine Pranobex, the active ingredient in Imunovir, is an immunomodulator presented as an oral formulation for oral use. It is employed to support the immune response in viral infections such as herpes simplex and influenza, primarily in adult patients.

GNH USA supplies Imunovir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Imunovir acts as an immunomodulatory antiviral that enhances host defenses against several viral pathogens.

Herpes simplex virus infections: helps reduce lesion frequency and duration by enhancing host antiviral immunity and may accelerate healing. Influenza: supports the immune system to limit viral replication and may shorten the course of illness. Other viral infections: used as an adjunct to standard therapy to improve immune response in various viral diseases.

Imunovir may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects: - Leukopenia: reduced white blood cell count requiring monitoring. - Thrombocytopenia: decreased platelet levels that may increase bleeding risk. - Hepatic enzyme elevation: abnormal liver function tests indicating possible liver stress.

Before initiating Imunovir, several safety considerations should be observed.

Assess immune status: evaluate baseline lymphocyte count prior to therapy. Monitor liver function: perform periodic hepatic enzyme tests during treatment. Monitor renal function: adjust use if significant renal impairment is present. Avoid in known hypersensitivity: discontinue immediately if allergic reactions occur. Pregnancy and lactation: use only if potential benefits outweigh uncertain risks. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Imunovir can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Immunosuppressive agents: may diminish the therapeutic effect of Imunovir. - Live attenuated vaccines: concurrent use can alter vaccine efficacy.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may increase bleeding tendency. - Corticosteroids: may potentiate immunomodulatory activity. - Alcohol: may exacerbate hepatic side effects.